We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Calls for Contamination Risk Testing in Shared Manufacturing Facilities
EMA Calls for Contamination Risk Testing in Shared Manufacturing Facilities
January 10, 2013
Drug and active substance manufacturers in the EU need to determine the threshold for cross-contamination when multiple medical products are produced in shared facilities, according to draft guidance from the European Medicines Agency.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor